How can bruxism cause headaches? Bruxism causes morning, tension, and migraine headaches via jaw muscle fatigue and trigeminal sensitization. Learn the types, triggers, and relief options.
Written by Ann C. McCulloch, MBA | Medically Reviewed by Bradley Allen Eli, DMD, MS
SSRIs (selective serotonin reuptake inhibitors) are among the most widely prescribed antidepressants in the world — and jaw clenching, known clinically as bruxism, is a well-documented side effect. The mechanism is not fully established, but current evidence points to SSRI-driven changes in serotonin and dopamine activity that disrupt the central nervous system pathways governing jaw muscle control. The effect is reversible: clenching typically begins within the first three weeks of starting an SSRI and resolves within three to four weeks of stopping.
Among all classes of prescription medications, antidepressants carry the strongest pharmacovigilance signal for bruxism. When researchers analyzed the World Health Organization’s global pharmacovigilance database (VigiBase®), they found that patients taking antidepressants were approximately ten times more likely to report bruxism than patients on any other medication class — one of the most striking drug-bruxism associations in the post-marketing literature. These findings were published in BMC Psychiatry.
A 2023 analysis in the British Journal of Clinical Pharmacology, drawing on over 564 adult bruxism reports from the same WHO database, confirmed and extended these results. Among all antidepressants examined, sertraline had the highest number of associated reports, followed by escitalopram, venlafaxine, vortioxetine, citalopram, paroxetine, fluoxetine, and duloxetine — a list that spans both SSRIs and SNRIs. Notably, the study also suggested that norepinephrine reuptake inhibition may contribute more strongly to the bruxism signal than serotonin inhibition alone, which may explain why SNRIs also carry significant risk.
The term “bruxism” encompasses two overlapping behaviors: jaw clenching and teeth grinding. Both can occur during sleep (sleep bruxism) or while awake. SSRI-related bruxism appears to involve both patterns. For patients whose bruxism is also tied to anxiety, the relationship between anxiety and jaw clenching is explored in more detail in that dedicated article.
The following common SSRI medications, listed with their brand names, have been associated with bruxism in the clinical literature:
Of these, sertraline (Zoloft), citalopram (Celexa), and vortioxetine (Trintellix) showed the strongest statistically significant associations with bruxism in pharmacovigilance analyses.
Serotonin-norepinephrine reuptake inhibitors (SNRIs) are a closely related drug class and carry a comparable bruxism risk profile. The most commonly implicated SNRIs are:
Both duloxetine and venlafaxine showed a statistically significant association with bruxism in pharmacovigilance data.
Not all antidepressants carry the same risk. Researchers comparing different drug classes found no significant association with bruxism in either the tricyclic antidepressant (TCA) class or the monoamine oxidase inhibitor (MAOI) class. This distinction matters clinically — especially for patients managing both a mental health condition and a jaw disorder such as a TMJ flare-up.
Common tricyclic antidepressants, with their brand names, include:
“The best antidepressants for TMJ patients are the ones that do not cause jaw clenching, as clenching can seriously aggravate TMJ disorders. Because tricyclic antidepressants also help with chronic pain, drugs in this class are sometimes the best alternative to SSRIs if they are causing jaw clenching,” explains Bradley Eli, DMD, MS, an orofacial pain specialist. Please note that any medication changes should be directed by a healthcare professional.
Common MAOI antidepressants, with their brand names, include:
MAOIs are rarely prescribed today due to significant dietary restrictions and drug interaction risks, and they are generally not appropriate as a first-line alternative to SSRIs. Any antidepressant switch should be evaluated and managed by a prescribing physician.
The precise mechanisms behind SSRI-induced bruxism are still being investigated, but the most widely accepted hypothesis involves the interplay between serotonin and dopamine in the central nervous system.
SSRIs increase the availability of serotonin at neuronal synapses by blocking its reuptake — the intended effect for treating depression and anxiety disorders. However, elevated serotonin levels also appear to suppress dopaminergic activity in the nigrostriatal pathway, the brain circuit responsible for coordinated movement. This suppression of dopamine may result in involuntary, repetitive jaw muscle contractions — a mechanism similar to other drug-induced movement disorders such as akathisia and tardive dyskinesia.
Several studies have shown that rhythmic jaw movements like bruxism are regulated in part by CNS neurotransmitter levels. Emerging research is also identifying genetic variants in serotonin and dopamine receptors that may explain why only a subset of patients experience jaw clenching on SSRIs, even at equivalent doses. Additionally, independent research is now revealing that stress can amplify the bruxism response, compounding the pharmacological effect in patients already carrying high psychological tension in their jaw muscles.
Constant jaw clenching quickly leads to muscle fatigue, jaw strain, and generalized jaw pain. A 2020 report by the National Academy of Sciences identified acute jaw pain as a major risk factor for developing a chronic TMJ disorder if left untreated — meaning that waiting three to four weeks for clenching to resolve on its own after stopping an SSRI is not a safe management strategy.
Several evidence-informed approaches can be used in parallel while medication decisions are being made with a provider:
All of these conservative measures — jaw rest, gentle physical therapy exercises, hot and cold packs, and an anterior bite guard — are included as part of the Speed2Treat® Home Healing Kit, a comprehensive self-care approach to jaw pain relief. If you are in pain from jaw clenching, you don’t have to wait three to four weeks for the clenching to stop before finding relief.
If SSRI-related bruxism has triggered headaches, it may also be helpful to read about whether bruxism can cause headaches and what treatment options are available.
If you suspect your antidepressant is causing jaw clenching, these questions can help guide a productive conversation with your prescriber or dentist:
Not all patients who take SSRIs experience jaw clenching, but the class as a whole carries a significantly elevated bruxism risk compared to other medications. Pharmacovigilance data consistently identifies sertraline (Zoloft), escitalopram (Lexapro), paroxetine (Paxil), and fluoxetine (Prozac) as the SSRIs most frequently linked to bruxism reports. Individual susceptibility appears to vary and may be influenced by genetic differences in serotonin and dopamine receptor function.
Jaw clenching from an SSRI typically begins within the first two to three weeks of starting the medication. In some patients it may appear sooner, particularly after a dose increase. Because the onset tends to be gradual, many patients do not immediately connect the new symptom to the antidepressant.
For most patients, jaw clenching resolves within three to four weeks of discontinuing the offending medication. However, stopping or changing an antidepressant should never be done without guidance from a prescribing physician, as abrupt discontinuation carries its own risks. Conservative jaw care — including a bite guard, jaw rest, and physical therapy — can help protect the jaw and manage pain during the transition period.
If left unaddressed for an extended period, chronic jaw clenching can contribute to tooth wear, temporomandibular joint inflammation, and persistent muscle dysfunction that may develop into a chronic TMJ disorder. Early intervention — with an anterior bite guard, jaw rest, and physical therapy — significantly reduces the risk of lasting joint and dental damage.
Yes. Tricyclic antidepressants such as amitriptyline (Elavil) and nortriptyline (Pamelor) have not been associated with bruxism in pharmacovigilance studies. They may be a particularly useful alternative for patients with co-existing TMJ pain, as they also have analgesic properties. MAOIs are similarly not linked to bruxism but are rarely appropriate as a first-line alternative. Any antidepressant switch must be managed by a prescribing physician.
While medication changes take weeks to take effect, jaw pain can be addressed in the short term with jaw rest, heat and cold therapy, gentle stretching exercises, and an anterior bite guard that reduces bruxing forces on the jaw joints. The QuickSplint® anterior bite guard, combined with the Speed2Treat® Home Healing Kit, provides a structured conservative approach to jaw pain relief that can be started immediately without waiting for the clenching to stop.
